scholarly journals Fibroblast Growth Factor 21 Signaling Activation by Selected Bioactive Compounds from Cocoa Shell Modulated Metabolism and Mitochondrial Function in Hepatocytes

2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 459-459
Author(s):  
Miguel Rebollo-Hernanz ◽  
Lindsey Willis ◽  
Yolanda Aguilera ◽  
María A Martin-Cabrejas ◽  
Elvira Gonzalez de Mejia

Abstract Objectives To evaluate the effect of selected bioactive compounds from cocoa shell and its aqueous extract on the activation of fibroblast growth factor 21 (FGF21) signaling in hepatocytes and the resulting modulation of lipid and glucose metabolism, oxidative stress, and mitochondrial function. Methods The bioactive compounds from cocoa shells were extracted using water and characterized by UPLC-MS/MS. An in vitro model of non-alcoholic fatty liver disease was used: HepG2 cells were co-treated with either pure theobromine (TH), protocatechuic acid (PCA), procyanidin B2 (PB2), epicatechin (EPI), catechin (CAT) (10–50 µmol L−1), or the aqueous extract from cocoa shells (CAE, 20–100 µg mL−1) in the presence or absence of palmitic acid (PA, 500 µmol L−1). FGF21 receptor interaction with cocoa shell phytochemical was evaluated in silico. Biomarkers of cell metabolism were assessed 24 h after the co-treatment in cell supernatants and lysates using chemical, biochemical, and immunochemical techniques. Results Phytochemicals from cocoa shell were able to interact in silico with FGF21 receptor (biding energies from −6.0 to −11.0 kcal mol−1) denoting a potential interaction causing FGF21 receptor response. FGF21 hepatic signaling was activated (1.1 to 2.3-fold enhance in ERK1/2 phosphorylation). CAE, TH, PCA, PB2, EPI, and CAT diminished PA-elicited lipid accumulation (5–86%, P < 0.05) by reducing fatty acid synthase expression, and stimulated lipolysis (1–87%, P < 0.05) through the up-regulation of lipoprotein lipase expression. CAE and therein-bioactive compounds, mainly TH and PCA, promoted glucose uptake (4–35%, P < 0.05) via the increase in the phosphorylation of the insulin receptor (2.2-fold, P < 0.05), protein kinase B (2.8-fold, P < 0.05), AMPKα (2.0-fold, P < 0.05), and ERK1/2 (2.8-fold, P < 0.05) phosphorylation. Oxidative stress was prevented (50–100%, P < 0.05), and the loss of mitochondrial content (15–100%, P < 0.05) and function, measured as ATP production, alleviated (28–100%, P < 0.05). Conclusions Results demonstrated that the major bioactive compounds, primarily TH and PCA, found in cocoa shell could activate FGF21 signaling and regulated hepatic lipid and glucose metabolism, preventing insulin resistance, oxidative stress, and mitochondrial dysfunction. Funding Sources USDA-NIFA-HATCH, and the Spanish Ministry of Science and Innovation.

2021 ◽  
Author(s):  
Xinghao Jiang ◽  
Yimeng Zou ◽  
Yeboah Kwaku Opoku ◽  
Shijie Liu ◽  
Dan Wang ◽  
...  

Abstract Epidemiological investigations have shown an elevated expression of fibroblast growth factor 21 (FGF21) in the serum of patients with hyperuricemia. However, the effect of FGF21 on hyperuricemic nephropathy is still unknown. The purpose of this study, therefore, was to explore the effect and mechanism of action of FGF21 on hyperuricemic nephropathy. The level of FGF21 in PBMCs was determined in 10 patients with hyperuricemic nephropathy. Hyperuricemic mice models were induced in wild-type C57BL/6 and FGF21 knockout mice. Six mice in each group were treated with FGF21 at a dose of 1mg/kg and 5mg/kg for 30 days. For the in vitro studies, glomerular mesangial cells were exposed to lipopolysaccharide and monosodium uric acid to induce inflammation. This was followed by treatment with 100nM, 1000nM of FGF21 for 72 h to observe the therapeutic effect. The levels of FGF21 in patients with hyperuricemic nephropathy were elevated. Also, FGF21 knockout mice experienced more severe nephropathy compared to the WT mice. This was characterized by an increase in inflammatory factors and fibrosis in the kidney, which was reversed by exogenous FGF21 treatment. FGF21 recorded a significant therapeutic effect through the activation of Akt/Nrf2 signal pathway in both in vivo and in vitro studies. However, the effect increasing effect of FGF21 on Nrf2 was reduced by the addition of Akt inhibitor GSK690693. In conclusion, our study found for the first time that FGF21 can significantly improve hyperuricemic nephropathy through the promotion of the Akt/Nrf2 signalling pathway leading to improvement in oxidative stress.


2015 ◽  
Vol 83 (6) ◽  
pp. 820-827 ◽  
Author(s):  
Manassawee Korwutthikulrangsri ◽  
Pat Mahachoklertwattana ◽  
Suwannee Chanprasertyothin ◽  
Sarunyu Pongratanakul ◽  
Preamrudee Poomthavorn

2021 ◽  
Vol 8 ◽  
Author(s):  
Miao Chen ◽  
Jiawei Zhong ◽  
Zhen Wang ◽  
Hongfei Xu ◽  
Heng Chen ◽  
...  

Aim: The structural and electrical changes in the atrium, also known as atrial remodeling, are the main characteristics of atrial fibrillation (AF). Fibroblast growth factor 21 (Fgf21) is an important endocrine factor, which has been shown to play an important role in cardiovascular diseases. However, the effects of Fgf21 on atrial remodeling have not been addressed yet. The purpose of the present study is to evaluate the effects of Fgf21 on atrial remodeling.Methods and Results: Adult mice were treated with Ang II, and randomly administrated with or without Fgf21 for 2 weeks. The susceptibility to AF was assessed by electrical stimulation and optical mapping techniques. Here, we found that Fgf21 administration attenuated the inducibility of atrial fibrillation/atrial tachycardia (AF/AT), improved epicardial conduction velocity in the mice atria. Mechanistically, Fgf21 protected against atrial fibrosis and reduced oxidative stress of the atria. Consistently, in vitro study also demonstrated that Fgf21 blocked the upregulation of collagen by Tgf-β in fibroblasts and attenuated tachypacing-induced oxidative stress including reactive oxygen species (ROS), Tgf-β, and ox-CaMKII in atrial myocytes. We further found that Fgf21 attenuated oxidative stress by inducing antioxidant genes, such as SOD2 and UCP3. Fgf21 also improved tachypacing-induced myofibril degradation, downregulation of L-type calcium channel, and upregulation of p-RyR2, which implicated protective effects of Fgf21 on structural and electrical remodeling in the atria. Moreover, Nrf2 was identified as a downstream of Fgf21 and partly mediated Fgf21-induced antioxidant gene expression in atrial myocytes.Conclusion: Fgf21 administration effectively suppressed atrial remodeling by reducing oxidative stress, which provides a novel therapeutic insight for AF.


Sign in / Sign up

Export Citation Format

Share Document